Global Market for Cancer Immunotherapy Estimated at US$135.2 B in 2024 to Reach US$236.9 B by 2030
A new report from Industry Experts Inc, on " Cancer Immunotherapy ," is introduced. As per this market research report, the global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030. The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand for more effective treatment options. Oncolytic viral therapies and cancer vaccines use viruses to specifically target and destroy cancer cells, while Checkpoint inhibitors and CAR-T cell therapies are increasingly employed to treat lung cancer and melanoma. These therapies stimulate immune responses and are gaining attention due to their precise targeting and reduced side effects, further driving market demand. The Monoclonal Antibodies segment dominates the cancer immunotherapy market, holding a proj...